nach oben

Erschienen in:

05.08.2020 | Review

Bilateral lesions of the basal ganglia and thalami (central grey matter)—pictorial review

verfasst von: Sofie Van Cauter, Mariasavina Severino, Rosamaria Ammendola, Brecht Van Berkel, Hrvoje Vavro, Luc van den Hauwe, Zoran Rumboldt

Erschienen in: Neuroradiology | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

The basal ganglia and thalami are paired deep grey matter structures with extensive metabolic activity that renders them susceptible to injury by various diseases. Most pathological processes lead to bilateral lesions, which may be symmetric or asymmetric, frequently showing characteristic patterns on imaging studies. In this comprehensive pictorial review, the most common and/or typical genetic, acquired metabolic/toxic, infectious, inflammatory, vascular and neoplastic pathologies affecting the central grey matter are subdivided according to the preferential location of the lesions: in the basal ganglia, in the thalami or both. The characteristic imaging findings are described with emphasis on the differential diagnosis and clinical context.

Hoch MJ, Bruno MT, Faustin A, Cruz N, Mogilner AY, Crandall L, Wisniewski T, Devinsky O, Shepherd TM (2019) 3T MRI whole-brain microscopy discrimination of subcortical anatomy, part 2: basal forebrain. AJNR Am J Neuroradiol 40(7):1095–1105. https://doi.org/10.3174/ajnr.A6088CrossRefPubMedPubMedCentral

ten Donkelaar HJ, Lammens M, Akira H (2014) Clinical neuroembryology: development and developmental disorders of the human central nervous system. Springer, New York

Dixon AKB, David J.; Ellis, Harold; Logan Bari M. (2015) Brain: selected images. In: Human sectional anatomy: atlas of body sections, CT and MRI images, fourth edition. CRC

Adams LC, Bressem K, Boker SM, Bender YY, Norenberg D, Hamm B, Makowski MR (2017) Diagnostic performance of susceptibility-weighted magnetic resonance imaging for the detection of calcifications: a systematic review and meta-analysis. Sci Rep 7(1):15506. https://doi.org/10.1038/s41598-017-15860-1CrossRefPubMedPubMedCentral

Henkelman RM, Watts JF, Kucharczyk W (1991) High signal intensity in MR images of calcified brain tissue. Radiology 179(1):199–206. https://doi.org/10.1148/radiology.179.1.1848714CrossRefPubMed

Tullo S, Patel R, Devenyi GA, Salaciak A, Bedford SA, Farzin S, Wlodarski N, Tardif CL, Group P-AR, JCS B, Chakravarty MM (2019) MR-based age-related effects on the striatum, globus pallidus, and thalamus in healthy individuals across the adult lifespan. Hum Brain Mapp 40(18):5269–5288. https://doi.org/10.1002/hbm.24771CrossRefPubMedPubMedCentral

Baertling F, Rodenburg RJ, Schaper J, Smeitink JA, Koopman WJ, Mayatepek E, Morava E, Distelmaier F (2014) A guide to diagnosis and treatment of Leigh syndrome. J Neurol Neurosurg Psychiatry 85(3):257–265. https://doi.org/10.1136/jnnp-2012-304426CrossRefPubMed

Arii J, Tanabe Y (2000) Leigh syndrome: serial MR imaging and clinical follow-up. AJNR Am J Neuroradiol 21(8):1502–1509PubMedPubMedCentral

Kolker S, Christensen E, Leonard JV, Greenberg CR, Boneh A, Burlina AB, Burlina AP, Dixon M, Duran M, Garcia Cazorla A, Goodman SI, Koeller DM, Kyllerman M, Muhlhausen C, Muller E, Okun JG, Wilcken B, Hoffmann GF, Burgard P (2011) Diagnosis and management of glutaric aciduria type I--revised recommendations. J Inherit Metab Dis 34(3):677–694. https://doi.org/10.1007/s10545-011-9289-5CrossRefPubMedPubMedCentral

10.

Nunes J, Loureiro S, Carvalho S, Pais RP, Alfaiate C, Faria A, Garcia P, Diogo L (2013) Brain MRI findings as an important diagnostic clue in glutaric aciduria type 1. Neuroradiol J 26(2):155–161. https://doi.org/10.1177/197140091302600204CrossRefPubMedPubMedCentral

11.

Christian CW, States LJ (2017) Medical mimics of child abuse. AJR Am J Roentgenol 208(5):982–990. https://doi.org/10.2214/AJR.16.17450CrossRefPubMed

12.

Ranjan A, Kalita J, Kumar S, Bhoi SK, Misra UK (2015) A study of MRI changes in Wilson disease and its correlation with clinical features and outcome. Clin Neurol Neurosurg 138:31–36. https://doi.org/10.1016/j.clineuro.2015.07.013CrossRefPubMed

13.

Kim TJ, Kim IO, Kim WS, Cheon JE, Moon SG, Kwon JW, Seo JK, Yeon KM (2006) MR imaging of the brain in Wilson disease of childhood: findings before and after treatment with clinical correlation. AJNR Am J Neuroradiol 27(6):1373–1378PubMedPubMedCentral

14.

Sinha S, Taly AB, Ravishankar S, Prashanth LK, Venugopal KS, Arunodaya GR, Vasudev MK, Swamy HS (2006) Wilson’s disease: cranial MRI observations and clinical correlation. Neuroradiology 48(9):613–621. https://doi.org/10.1007/s00234-006-0101-4CrossRefPubMed

15.

Scahill RI, Andre R, Tabrizi SJ, Aylward EH (2017) Structural imaging in premanifest and manifest Huntington disease. Handb Clin Neurol 144:247–261. https://doi.org/10.1016/B978-0-12-801893-4.00020-1CrossRefPubMed

16.

Hobbs NZ, Barnes J, Frost C, Henley SM, Wild EJ, Macdonald K, Barker RA, Scahill RI, Fox NC, Tabrizi SJ (2010) Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study. AJNR Am J Neuroradiol 31(6):1036–1041. https://doi.org/10.3174/ajnr.A2018CrossRefPubMedPubMedCentral

17.

Amaral LL, Gaddikeri S, Chapman PR, Roy R, Gaddikeri RS, Marussi VH, Bag AK (2015) Neurodegeneration with brain iron accumulation: clinicoradiological approach to diagnosis. J Neuroimaging 25(4):539–551. https://doi.org/10.1111/jon.12195CrossRefPubMed

18.

McNeill A, Birchall D, Hayflick SJ, Gregory A, Schenk JF, Zimmerman EA, Shang H, Miyajima H, Chinnery PF (2008) T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 70(18):1614–1619. https://doi.org/10.1212/01.wnl.0000310985.40011.d6CrossRefPubMedPubMedCentral

19.

Beppu T (2013) The role of MR imaging in assessment of brain damage from carbon monoxide poisoning: a review of the literature. Am J Neuroradiol 35(4):625–631. https://doi.org/10.3174/ajnr.A3489CrossRefPubMed

20.

Jeon SB, Sohn CH, Seo DW, Oh BJ, Lim KS, Kang DW, Kim WY (2018) Acute brain lesions on magnetic resonance imaging and delayed neurological sequelae in carbon monoxide poisoning. JAMA Neurol 75(4):436–443. https://doi.org/10.1001/jamaneurol.2017.4618CrossRefPubMedPubMedCentral

21.

Wisnowski JL, Panigrahy A, Painter MJ, Watchko JF (2014) Magnetic resonance imaging of bilirubin encephalopathy: current limitations and future promise. Semin Perinatol 38(7):422–428. https://doi.org/10.1053/j.semperi.2014.08.005CrossRefPubMedPubMedCentral

22.

Rovira A, Alonso J, Cordoba J (2008) MR imaging findings in hepatic encephalopathy. AJNR Am J Neuroradiol 29(9):1612–1621. https://doi.org/10.3174/ajnr.A1139CrossRefPubMedPubMedCentral

23.

Choi JW, Moon WJ (2019) Gadolinium deposition in the brain: current updates. Korean J Radiol 20(1):134–147. https://doi.org/10.3348/kjr.2018.0356CrossRefPubMed

24.

Gulani V, Calamante F, Shellock FG, Kanal E, Reeder SB, International Society for Magnetic Resonance in M (2017) Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol 16(7):564–570. https://doi.org/10.1016/S1474-4422(17)30158-8CrossRefPubMed

25.

Zakharov S, Kotikova K, Vaneckova M, Seidl Z, Nurieva O, Navratil T, Caganova B, Pelclova D (2016) Acute methanol poisoning: prevalence and predisposing factors of haemorrhagic and non-haemorrhagic brain lesions. Basic Clin Pharmacol Toxicol 119(2):228–238. https://doi.org/10.1111/bcpt.12559CrossRefPubMed

26.

Taheri MS, Moghaddam HH, Moharamzad Y, Dadgari S, Nahvi V (2010) The value of brain CT findings in acute methanol toxicity. Eur J Radiol 73(2):211–214. https://doi.org/10.1016/j.ejrad.2008.11.006CrossRefPubMed

27.

Kumar G, Goyal MK (2010) Lentiform fork sign: a unique MRI picture. Is metabolic acidosis responsible? Clin Neurol Neurosurg 112(9):805–812. https://doi.org/10.1016/j.clineuro.2010.06.006CrossRefPubMed

28.

Kim DM, Lee IH, Song CJ (2016) Uremic encephalopathy: MR imaging findings and clinical correlation. AJNR Am J Neuroradiol 37(9):1604–1609. https://doi.org/10.3174/ajnr.A4776CrossRefPubMedPubMedCentral

29.

Bathla G, Policeni B, Agarwal A (2014) Neuroimaging in patients with abnormal blood glucose levels. AJNR Am J Neuroradiol 35(5):833–840. https://doi.org/10.3174/ajnr.A3486CrossRefPubMedPubMedCentral

30.

Wong DS, Poskitt KJ, Chau V, Miller SP, Roland E, Hill A, Tam EW (2013) Brain injury patterns in hypoglycemia in neonatal encephalopathy. AJNR Am J Neuroradiol 34(7):1456–1461. https://doi.org/10.3174/ajnr.A3423CrossRefPubMedPubMedCentral

31.

Aquino JH, Spitz M, Pereira JS (2015) Hemichorea-hemiballismus as the first sign of type 1b diabetes during adolescence and its recurrence in the setting of infection. J Child Neurol 30(10):1362–1365. https://doi.org/10.1177/0883073814553972CrossRefPubMed

32.

Oh SH, Lee KY, Im JH, Lee MS (2002) Chorea associated with non-ketotic hyperglycemia and hyperintensity basal ganglia lesion on T1-weighted brain MRI study: a meta-analysis of 53 cases including four present cases. J Neurol Sci 200(1–2):57–62. https://doi.org/10.1016/s0022-510x(02)00133-8CrossRefPubMed

33.

Kelley BP, Patel SC, Marin HL, Corrigan JJ, Mitsias PD, Griffith B (2017) Autoimmune encephalitis: pathophysiology and imaging review of an overlooked diagnosis. AJNR Am J Neuroradiol 38(6):1070–1078. https://doi.org/10.3174/ajnr.A5086CrossRefPubMedPubMedCentral

34.

Crespo-Burillo JA, Hernando-Quintana N, Ruiz-Palomino P, Martin-Martinez J (2015) Chorea secondary to striatal encephalitis due to anti-CV2/CRMP5 antibodies. Case description and review of the literature. Neurologia 30(7):451–453. https://doi.org/10.1016/j.nrl.2013.10.007CrossRefPubMed

35.

da Rocha AJ, Nunes RH, Maia AC Jr, do Amaral LL (2015) Recognizing autoimmune-mediated encephalitis in the differential diagnosis of limbic disorders. AJNR Am J Neuroradiol 36(12):2196–2205. https://doi.org/10.3174/ajnr.A4408CrossRefPubMedPubMedCentral

36.

Charlier C, Dromer F, Leveque C, Chartier L, Cordoliani YS, Fontanet A, Launay O, Lortholary O, French Cryptococcosis Study G (2008) Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era. PLoS One 3(4):e1950. https://doi.org/10.1371/journal.pone.0001950CrossRefPubMedPubMedCentral

37.

Corti M, Villafane MF, Negroni R, Arechavala A, Maiolo E (2008) Magnetic resonance imaging findings in AIDS patients with central nervous system cryptococcosis. Rev Iberoam Micol 25(4):211–214. https://doi.org/10.1016/s1130-1406(08)70051-2CrossRefPubMed

38.

Zhong Y, Zhou Z, Fang X, Peng F, Zhang W (2017) Magnetic resonance imaging study of cryptococcal neuroradiological lesions in HIV-negative cryptococcal meningitis. Eur J Clin Microbiol Infect Dis 36(8):1367–1372. https://doi.org/10.1007/s10096-017-2941-8CrossRefPubMed

39.

Lou X, Ma L, Wang FL, Tang ZP, Huang H, Cai YQ, Wong EH (2009) Susceptibility-weighted imaging in the diagnosis of early basal ganglia germinoma. AJNR Am J Neuroradiol 30(9):1694–1699. https://doi.org/10.3174/ajnr.A1696CrossRefPubMedPubMedCentral

40.

Phi JH, Cho BK, Kim SK, Paeng JC, Kim IO, Kim IH, Kim DG, Jung HW, Kim JE, Wang KC (2010) Germinomas in the basal ganglia: magnetic resonance imaging classification and the prognosis. J Neuro-Oncol 99(2):227–236. https://doi.org/10.1007/s11060-010-0119-7CrossRef

41.

Patterson MC (2013) Gangliosidoses. Handb Clin Neurol 113:1707–1708. https://doi.org/10.1016/B978-0-444-59565-2.00039-3CrossRefPubMed

42.

Gururaj A, Sztriha L, Hertecant J, Johansen JG, Georgiou T, Campos Y, Drousiotou A, d’Azzo A (2005) Magnetic resonance imaging findings and novel mutations in GM1 gangliosidosis. J Child Neurol 20(1):57–60. https://doi.org/10.1177/08830738050200010901CrossRefPubMed

43.

Steenweg ME, Vanderver A, Blaser S, Bizzi A, de Koning TJ, Mancini GM, van Wieringen WN, Barkhof F, Wolf NI, van der Knaap MS (2010) Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain 133(10):2971–2982. https://doi.org/10.1093/brain/awq257CrossRefPubMedPubMedCentral

44.

Autti T, Joensuu R, Aberg L (2007) Decreased T2 signal in the thalami may be a sign of lysosomal storage disease. Neuroradiology 49(7):571–578. https://doi.org/10.1007/s00234-007-0220-6CrossRefPubMed

45.

Kumar D, Ramanathan S, Khanna M, Palaniappan Y (2014) Bithalamic T2 hypointensity: a diagnostic clue for Sandhoff’s disease. Neurol India 62(4):481–482. https://doi.org/10.4103/0028-3886.141311CrossRefPubMed

46.

Cocozza S, Russo C, Pontillo G, Pisani A, Brunetti A (2018) Neuroimaging in Fabry disease: current knowledge and future directions. Insights Imaging 9(6):1077–1088. https://doi.org/10.1007/s13244-018-0664-8CrossRefPubMedPubMedCentral

47.

Aydin K, Sencer S, Demir T, Ogel K, Tunaci A, Minareci O (2002) Cranial MR findings in chronic toluene abuse by inhalation. AJNR Am J Neuroradiol 23(7):1173–1179PubMedPubMedCentral

48.

Zuccoli G, Santa Cruz D, Bertolini M, Rovira A, Gallucci M, Carollo C, Pipitone N (2009) MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol 30(1):171–176. https://doi.org/10.3174/ajnr.A1280CrossRefPubMedPubMedCentral

49.

Manzo G, De Gennaro A, Cozzolino A, Serino A, Fenza G, Manto A (2014) MR imaging findings in alcoholic and nonalcoholic acute Wernicke’s encephalopathy: a review. Biomed Res Int 2014:503596–503512. https://doi.org/10.1155/2014/503596CrossRefPubMedPubMedCentral

50.

Mach JC, Russell J (2020) A combined case of Wernicke and metronidazole induced encephalopathy? Overlapping pathophysiologic pathways and MR imaging features. Clin Neurol Neurosurg 196:106034. https://doi.org/10.1016/j.clineuro.2020.106034CrossRefPubMed

51.

Kim E, Na DG, Kim EY, Kim JH, Son KR, Chang KH (2007) MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. AJNR Am J Neuroradiol 28(9):1652–1658. https://doi.org/10.3174/ajnr.A0655CrossRefPubMedPubMedCentral

52.

U-King-Im JM, Yu E, Bartlett E, Soobrah R, Kucharczyk W (2011) Acute hyperammonemic encephalopathy in adults: imaging findings. AJNR Am J Neuroradiol 32(2):413–418. https://doi.org/10.3174/ajnr.A2290CrossRefPubMedPubMedCentral

53.

Reis E, Coolen T, Lolli V (2020) MRI findings in acute hyperammonemic encephalopathy: three cases of different etiologies: teaching point: to recognize MRI findings in acute hyperammonemic encephalopathy. J Belg Soc Radiol 104(1):9. https://doi.org/10.5334/jbsr.2017CrossRefPubMedPubMedCentral

54.

Wu X, Wu W, Pan W, Wu L, Liu K, Zhang HL (2015) Acute necrotizing encephalopathy: an underrecognized clinicoradiologic disorder. Mediat Inflamm 2015:792578–792510. https://doi.org/10.1155/2015/792578CrossRef

55.

Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B (2020) COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 296(2):E119–E120. https://doi.org/10.1148/radiol.2020201187CrossRefPubMed

56.

Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, Sultan M, Easton A, Breen G, Zandi M, Coles JP, Manji H, Al-Shahi Salman R, Menon DK, Nicholson TR, Benjamin LA, Carson A, Smith C, Turner MR, Solomon T, Kneen R, Pett SL, Galea I, Thomas RH, Michael BD, CoroNerve Study G (2020) Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry doi:https://doi.org/10.1016/S2215-0366(20)30287-X

57.

Arauz A, Patino-Rodriguez HM, Vargas-Gonzalez JC, Arguelles-Morales N, Silos H, Ruiz-Franco A, Ochoa MA (2014) Clinical spectrum of artery of Percheron infarct: clinical-radiological correlations. J Stroke Cerebrovasc Dis 23(5):1083–1088. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.09.011CrossRefPubMed

58.

Lazzaro NA, Wright B, Castillo M, Fischbein NJ, Glastonbury CM, Hildenbrand PG, Wiggins RH, Quigley EP, Osborn AG (2010) Artery of Percheron infarction: imaging patterns and clinical spectrum. AJNR Am J Neuroradiol 31(7):1283–1289. https://doi.org/10.3174/ajnr.A2044CrossRefPubMedPubMedCentral

59.

Linn J, Pfefferkorn T, Ivanicova K, Muller-Schunk S, Hartz S, Wiesmann M, Dichgans M, Bruckmann H (2009) Noncontrast CT in deep cerebral venous thrombosis and sinus thrombosis: comparison of its diagnostic value for both entities. AJNR Am J Neuroradiol 30(4):728–735. https://doi.org/10.3174/ajnr.A1451CrossRefPubMedPubMedCentral

60.

Chen XY, Wang Q, Wang X, Wong KS (2017) Clinical features of thalamic stroke. Curr Treat Options Neurol 19(2):5. https://doi.org/10.1007/s11940-017-0441-xCrossRefPubMed

61.

Holekamp TF, Mollman ME, Murphy RK, Kolar GR, Kramer NM, Derdeyn CP, Moran CJ, Perrin RJ, Rich KM, Lanzino G, Zipfel GJ (2016) Dural arteriovenous fistula-induced thalamic dementia: report of 4 cases. J Neurosurg 124(6):1752–1765. https://doi.org/10.3171/2015.5.JNS15473CrossRefPubMed

62.

Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820. https://doi.org/10.1007/s00401-016-1545-1CrossRefPubMed

63.

Kleinschmidt-DeMasters BK, Mulcahy Levy JM (2018) H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis. Clin Neuropathol 37(2):53–63. https://doi.org/10.5414/NP301085CrossRefPubMedPubMedCentral

64.

Mondal G, Lee JC, Ravindranathan A, Villanueva-Meyer JE, Tran QT, Allen SJ, Barreto J, Gupta R, Doo P, Van Ziffle J, Onodera C, Devine P, Grenert JP, Samuel D, Li R, Metrock LK, Jin LW, Antony R, Alashari M, Cheshier S, Whipple NS, Bruggers C, Raffel C, Gupta N, Kline CN, Reddy A, Banerjee A, Hall MD, Mehta MP, Khatib Z, Maher OM, Brathwaite C, Pekmezci M, Phillips JJ, Bollen AW, Tihan T, Lucas JT Jr, Broniscer A, Berger MS, Perry A, Orr BA, Solomon DA (2020) Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition. Acta Neuropathol 139:1071–1088. https://doi.org/10.1007/s00401-020-02155-5CrossRefPubMedPubMedCentral

65.

Lolli V, Tampieri D, Melancon D, Delpilar Cortes M (2010) Imaging in primary central nervous system lymphoma. Neuroradiol J 23(6):680–689. https://doi.org/10.1177/197140091002300606CrossRefPubMed

66.

Guo R, Zhang X, Niu C, Xi Y, Yin H, Lin H, Chang T (2019) Primary central nervous system small lymphocytic lymphoma in the bilateral ventricles: two case reports. BMC Neurol 19(1):200. https://doi.org/10.1186/s12883-019-1430-3CrossRefPubMedPubMedCentral

67.

Yap KK, Sutherland T, Liew E, Tartaglia CJ, Pang M, Trost N (2012) Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay. J Med Imaging Radiat Oncol 56(2):179–186. https://doi.org/10.1111/j.1754-9485.2012.02345.xCrossRefPubMed

68.

Amrom D, Tanyalcin I, Verhelst H, Deconinck N, Brouhard GJ, Decarie JC, Vanderhasselt T, Das S, Hamdan FF, Lissens W, Michaud JL, Jansen AC (2014) Polymicrogyria with dysmorphic basal ganglia? Think tubulin! Clin Genet 85(2):178–183. https://doi.org/10.1111/cge.12141CrossRefPubMed

69.

Bahi-Buisson N, Poirier K, Fourniol F, Saillour Y, Valence S, Lebrun N, Hully M, Bianco CF, Boddaert N, Elie C, Lascelles K, Souville I, Consortium LI-T, Beldjord C, Chelly J (2014) The wide spectrum of tubulinopathies: what are the key features for the diagnosis? Brain 137(Pt 6):1676–1700. https://doi.org/10.1093/brain/awu082CrossRefPubMed

70.

Petrak B, Lisy J, Kraus J, Kyncl M, Zatrapa T (2008) Focal areas of high-signal intensity on brain T2-weighted magnetic resonance imaging scans are significant for the diagnosis of neurofibromatosis Von Recklinghausen type 1. Pediatrics 121(Supplement 2):S147. https://doi.org/10.1542/peds.2007-2022CCCCCCCrossRef

71.

Salman MS, Hossain S, Gorun S, Alqublan L, Bunge M, Rozovsky K (2018) Cerebellar radiological abnormalities in children with neurofibromatosis type 1: part 2 - a neuroimaging natural history study with clinical correlations. Cerebellum Ataxias 5:13. https://doi.org/10.1186/s40673-018-0092-zCrossRefPubMedPubMedCentral

72.

Friedrich RE, Nuding MA (2016) Optic pathway glioma and cerebral focal abnormal signal intensity in patients with neurofibromatosis type 1: characteristics, treatment choices and follow-up in 134 affected individuals and a brief review of the literature. Anticancer Res 36(8):4095–4121PubMed

73.

Manyam BV (2005) What is and what is not ‘Fahr’s disease’. Parkinsonism Relat Disord 11(2):73–80. https://doi.org/10.1016/j.parkreldis.2004.12.001CrossRefPubMed

74.

Quintans B, Oliveira J, Sobrido MJ (2018) Primary familial brain calcifications. Handb Clin Neurol 147:307–317. https://doi.org/10.1016/B978-0-444-63233-3.00020-8CrossRefPubMed

75.

Livingston JH, Stivaros S, Warren D, Crow YJ (2014) Intracranial calcification in childhood: a review of aetiologies and recognizable phenotypes. Dev Med Child Neurol 56(7):612–626. https://doi.org/10.1111/dmcn.12359CrossRefPubMed

76.

Livingston JH, Mayer J, Jenkinson E, Kasher P, Stivaros S, Berger A, Cordelli DM, Ferreira P, Jefferson R, Kutschke G, Lundberg S, Ounap K, Prabhakar P, Soh C, Stewart H, Stone J, van der Knaap MS, van Esch H, van Mol C, Wakeling E, Whitney A, Rice GI, Crow YJ (2014) Leukoencephalopathy with calcifications and cysts: a purely neurological disorder distinct from coats plus. Neuropediatrics 45(3):175–182. https://doi.org/10.1055/s-0033-1364180CrossRefPubMed

77.

Moore MM, Kanekar SG, Dhamija R (2008) Ethylene glycol toxicity: chemistry, pathogenesis, and imaging. Radiol Case Rep 3(1):122. https://doi.org/10.2484/rcr.v3i1.122CrossRefPubMed

78.

Rumboldt Z, Vavro H, Spero M (2019) Exogenuous toxins and CNS injuries. In: Barkhof F, Jäger R, Thurner M, Rovira A (eds) Clinical neuroradiology. Springer, Berlin. https://doi.org/10.1007/978-3-319-61423-6_66-1CrossRef

79.

Malhotra A, Mongelluzzo G, Wu X, Durand D, Kalra VB, LeSar B, Liu R (2017) Ethylene glycol toxicity: MRI brain findings. Clin Neuroradiol 27(1):109–113. https://doi.org/10.1007/s00062-016-0525-0CrossRefPubMed

80.

Boukobza M, Baud FJ, Gourlain H, Champion S, Malissin I, Megarbane B (2015) Neuroimaging findings and follow-up in two cases of severe ethylene glycol intoxication with full recovery. J Neurol Sci 359(1–2):343–346. https://doi.org/10.1016/j.jns.2015.11.023CrossRefPubMed

81.

Alleman AM (2014) Osmotic demyelination syndrome: central pontine myelinolysis and extrapontine myelinolysis. Semin Ultrasound CT MR 35(2):153–159. https://doi.org/10.1053/j.sult.2013.09.009CrossRefPubMed

82.

Garg P, Aggarwal A, Malhotra R, Dhall S (2019) Osmotic demyelination syndrome - evolution of extrapontine before pontine myelinolysis on magnetic resonance imaging. J Neurosci Rural Pract 10(1):126–135. https://doi.org/10.4103/jnrp.jnrp_240_18CrossRefPubMedPubMedCentral

83.

Hussain K, Walsh TJ, Chazen JL (2016) Brain MRI findings with vigabatrin therapy: case report and literature review. Clin Imaging 40(1):180–182. https://doi.org/10.1016/j.clinimag.2015.07.016CrossRefPubMed

84.

Hussain SA, Tsao J, Li M, Schwarz MD, Zhou R, Wu JY, Salamon N, Sankar R (2017) Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent. Epilepsia 58(4):674–682. https://doi.org/10.1111/epi.13712CrossRefPubMed

85.

Perugula ML, Lippmann S (2016) Fahr’s disease or Fahr’s syndrome? Innov Clin Neurosci 13(7–8):45–46PubMedPubMedCentral

86.

Lee YJ, Park S, Kim YW, Park KM, Kim IH, Park JH, Park BS (2018) A case of seizure revealing Fahr’s syndrome with primary hypoparathyroidism. Am J Case Rep 19:1430–1433. https://doi.org/10.12659/AJCR.913382CrossRefPubMedPubMedCentral

87.

Rudge P, Hyare H, Green A, Collinge J, Mead S (2018) Imaging and CSF analyses effectively distinguish CJD from its mimics. J Neurol Neurosurg Psychiatry 89(5):461–466. https://doi.org/10.1136/jnnp-2017-316853CrossRefPubMed

88.

Tschampa HJ, Zerr I, Urbach H (2007) Radiological assessment of Creutzfeldt-Jakob disease. Eur Radiol 17(5):1200–1211. https://doi.org/10.1007/s00330-006-0456-2CrossRefPubMed

89.

Maeda K, Sugihara Y, Shiraishi T, Hirai A, Satoh K (2019) Cortical hyperintensity on diffusion-weighted images as the presymptomatic marker of sporadic Creutzfeldt-Jakob disease. Intern Med 58(5):727–729. https://doi.org/10.2169/internalmedicine.1155-18CrossRefPubMed

90.

Baumann M, Hennes EM, Schanda K, Karenfort M, Kornek B, Seidl R, Diepold K, Lauffer H, Marquardt I, Strautmanis J, Syrbe S, Vieker S, Hoftberger R, Reindl M, Rostasy K (2016) Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): extending the spectrum of MOG antibody positive diseases. Mult Scler 22(14):1821–1829. https://doi.org/10.1177/1352458516631038CrossRefPubMed

91.

Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S, Belman AL (2016) Acute disseminated encephalomyelitis: updates on an inflammatory CNS syndrome. Neurology 87(9 Suppl 2):S38–S45. https://doi.org/10.1212/WNL.0000000000002825CrossRefPubMed

92.

Armangue T, Olive-Cirera G, Martinez-Hernandez E, Sepulveda M, Ruiz-Garcia R, Munoz-Batista M, Arino H, Gonzalez-Alvarez V, Felipe-Rucian A, Jesus Martinez-Gonzalez M, Cantarin-Extremera V, Concepcion Miranda-Herrero M, Monge-Galindo L, Tomas-Vila M, Miravet E, Malaga I, Arrambide G, Auger C, Tintore M, Montalban X, Vanderver A, Graus F, Saiz A, Dalmau J, Spanish Pediatric anti MOGSG (2020) Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study. Lancet Neurol 19(3):234–246. https://doi.org/10.1016/S1474-4422(19)30488-0CrossRefPubMed

93.

Beattie GC, Glaser CA, Sheriff H, Messenger S, Preas CP, Shahkarami M, Venkatesan A (2013) Encephalitis with thalamic and basal ganglia abnormalities: etiologies, neuroimaging, and potential role of respiratory viruses. Clin Infect Dis 56(6):825–832. https://doi.org/10.1093/cid/cis990CrossRefPubMed

94.

Rumboldt Z (2008) Imaging of topographic viral CNS infections. Neuroimaging Clin N Am 18(1):85–92; viii. https://doi.org/10.1016/j.nic.2007.12.006CrossRefPubMed

95.

Petropoulou KA, Gordon SM, Prayson RA, Ruggierri PM (2005) West Nile virus meningoencephalitis: MR imaging findings. AJNR Am J Neuroradiol 26(8):1986–1995PubMedPubMedCentral

96.

Akkoc G, Kadayifci EK, Karaaslan A, Atici S, Yakut N, Ocal Demir S, Soysal A, Bakir M (2016) Epstein-Barr virus encephalitis in an immunocompetent child: a case report and management of Epstein-Barr virus encephalitis. Case Rep Infect Dis 2016:7549252–7549254. https://doi.org/10.1155/2016/7549252CrossRefPubMedPubMedCentral

97.

Soares BP, Provenzale JM (2016) Imaging of herpesvirus infections of the CNS. Am J Roentgenol 206(1):39–48. https://doi.org/10.2214/ajr.15.15314CrossRef

98.

Smith AB, Smirniotopoulos JG, Rushing EJ (2008) From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic-pathologic correlation. Radiographics 28(7):2033–2058. https://doi.org/10.1148/rg.287085135CrossRefPubMed

99.

Roche AD, Rowley D, Brett FM, Looby S (2018) Concentric and eccentric target MRI signs in a case of HIV-associated cerebral toxoplasmosis. Case Rep Neurol Med 2018:9876514–9876513. https://doi.org/10.1155/2018/9876514CrossRefPubMedPubMedCentral

100.

Huang BY, Castillo M (2008) Hypoxic-ischemic brain injury: imaging findings from birth to adulthood. Radiographics 28(2):417–439; quiz 617. https://doi.org/10.1148/rg.282075066CrossRefPubMed

101.

Chao CP, Zaleski CG, Patton AC (2006) Neonatal hypoxic-ischemic encephalopathy: multimodality imaging findings. Radiographics 26(Suppl 1):S159–S172. https://doi.org/10.1148/rg.26si065504CrossRefPubMed

102.

Malamud MDN (1950) Status marmoratus: a form of cerebral palsy following either birth injury or inflammation of the central nervous system. J Pediatr 37(4):610–619. https://doi.org/10.1016/S0022-3476(50)80272-XCrossRefPubMed

103.

Rumboldt Z (2012) Hypertensive hematoma. In: Rumboldt Z, Castillo M, Huang BY, Rossi A (eds) Brain imaging with MRI and CT: an image pattern approach. Cambridge University Press, Cambridge, pp 364–365CrossRef

104.

Yang Z, Chen J, Mu J (2017) Simultaneous bilateral basal ganglia hemorrhage. Curr Drug Deliv 14(6):807–815. https://doi.org/10.2174/1567201813666160607202811CrossRefPubMed

105.

Yen CP, Lin CL, Kwan AL, Lieu AS, Hwang SL, Lin CN, Howng SL (2005) Simultaneous multiple hypertensive intracerebral haemorrhages. Acta Neurochir 147(4):393–399; discussion 399. https://doi.org/10.1007/s00701-004-0433-yCrossRefPubMed

106.

McKinney AM, Jagadeesan BD, Truwit CL (2013) Central-variant posterior reversible encephalopathy syndrome: brainstem or basal ganglia involvement lacking cortical or subcortical cerebral edema. AJR Am J Roentgenol 201(3):631–638. https://doi.org/10.2214/AJR.12.9677CrossRefPubMed

107.

Li K, Yang Y, Guo D, Sun D, Li C (2020) Clinical and MRI features of posterior reversible encephalopathy syndrome with atypical regions: a descriptive study with a large sample size. Front Neurol 11:194. https://doi.org/10.3389/fneur.2020.00194CrossRefPubMedPubMedCentral

Titel: Bilateral lesions of the basal ganglia and thalami (central grey matter)—pictorial review
verfasst von: Sofie Van Cauter
Mariasavina Severino
Rosamaria Ammendola
Brecht Van Berkel
Hrvoje Vavro
Luc van den Hauwe
Zoran Rumboldt
Publikationsdatum: 05.08.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: Neuroradiology / Ausgabe 12/2020
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI: https://doi.org/10.1007/s00234-020-02511-y

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Bilateral lesions of the basal ganglia and thalami (central grey matter)—pictorial review

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2020

Prediction of pituitary adenoma surgical consistency: radiomic data mining and machine learning on T2-weighted MRI

European Society of Neuroradiology (ESNR)

Intravoxel incoherent motion diffusion-weighted imaging for discrimination of benign and malignant retropharyngeal nodes

Magnetic resonance parkinsonism indices and interpeduncular angle in idiopathic normal pressure hydrocephalus and progressive supranuclear palsy

Tailored antiplatelet agent medication in clopidogrel hyporesponsive patients before stent-assisted coiling: single-center experience

Regional impairment of cortical and deep gray matter perfusion in preterm neonates with low-grade germinal matrix-intraventricular hemorrhage: an ASL study

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie